| Filed | As-Of/On | Form | Fullname | Symbol | Country | Industry | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypothetical Return | Hypothetical Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2008-02-07 | 2007-11-30 | N-CSRS | Enzon Pharmaceuticals Inc | ENZN | US | Medical-Biomedical/Gene | 100 | No Change | 0 | 0 % | $852 | $1,037 | $185 | 21.71 % | $0 | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2008-02-07 | 2007-11-30 | N-CSRS | Human Genome Sciences Inc | HGSI | US | Medical-Biomedical/Gene | 600 | Added More | 300 | 100.00 % | $3,516 | $16,428 | $12,912 | 367.23 % | $6,456 | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Human Genome Sciences Inc |
| 2008-02-07 | 2007-11-30 | N-CSRS | Elan Corp Plc | ELN | IE | Medical-Drugs | 0 | Sold All | -100 | -100 % | - | - | - | -75.16 % | $1,922 | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Elan Corp Plc |
| 2008-02-07 | 2007-11-30 | N-CSRS | Astrazeneca Plc | AZN | IT | Medical-Drugs | 0 | Sold All | -600 | -100 % | - | - | - | 17.25 % | $-4,008 | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Astrazeneca Plc |
| 2008-02-07 | 2007-11-30 | N-CSRS | Glaxosmithkline Plc | GSK | IT | Medical-Drugs | 0 | Sold All | -1,000 | -100 % | - | - | - | -0.58 % | $250 | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Glaxosmithkline Plc |
| 2008-02-07 | 2007-11-30 | N-CSRS | Beckman Coulter Inc | BEC | US | Medical Instruments | 200 | No Change | 0 | 0 % | $13,760 | $13,056 | $-704 | -5.11 % | $0 | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Beckman Coulter Inc |
| 2008-02-07 | 2007-11-30 | N-CSRS | Medarex Inc | MEDX | US | Therapeutics | 200 | No Change | 0 | 0 % | $1,914 | - | - | - % | | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Medarex Inc |
| 2008-02-07 | 2007-11-30 | N-CSRS | Immunomedics Inc | IMMU | US | Medical-Biomedical/Gene | 100 | No Change | 0 | 0 % | $230 | $353 | $123 | 53.47 % | $0 | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Immunomedics Inc |
| 2008-02-07 | 2007-11-30 | N-CSRS | Bristol-Myers Squibb Co | BMY | BE | Medical-Drugs | 800 | Added More | 200 | 33.33 % | $18,672 | $20,040 | $1,368 | 7.32 % | $342 | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Bristol-Myers Squibb Co |
| 2008-02-07 | 2007-11-30 | N-CSRS | November Ag | NBXA.DE | DE | Drug Delivery Systems | 2,007 | New Holding | 2,007 | 100 % | $1,726 | - | - | - % | | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of November Ag |
| 2008-02-07 | 2007-11-30 | N-CSRS | Medimmune Inc | MDU.BE | US | Medical-Biomedical/Gene | 0 | Sold All | -800 | -100 % | - | - | - | - % | | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Medimmune Inc |
| 2008-02-07 | 2007-11-30 | N-CSRS | Imclone Systems Inc | IMCL | US | Therapeutics | 300 | No Change | 0 | 0 % | $12,066 | - | - | - % | | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Imclone Systems Inc |
| 2008-02-07 | 2007-11-30 | N-CSRS | Hologic Inc | HOLX | US | X-Ray Equipment | 208 | New Holding | 208 | 100 % | $12,979 | $2,970 | $-10,009 | -77.11 % | $-10,009 | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Hologic Inc |
| 2008-02-07 | 2007-11-30 | N-CSRS | Pdl Biopharma Inc | PDLI | US | Medical-Biomedical/Gene | 500 | New Holding | 500 | 100 % | $7,300 | $3,930 | $-3,370 | -46.16 % | $-3,370 | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Pdl Biopharma Inc |
| 2008-02-07 | 2007-11-30 | N-CSRS | Millennium Pharmaceuticals Inc | MLNM | US | Medical-Biomedical/Gene | 900 | No Change | 0 | 0 % | $12,726 | - | - | - % | | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Millennium Pharmaceuticals Inc |
| 2008-02-07 | 2007-11-30 | N-CSRS | Valeant Pharmaceuticals International | VRX | US | Medical-Drugs | 200 | No Change | 0 | 0 % | $2,376 | $6,520 | $4,144 | 174.41 % | $0 | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Valeant Pharmaceuticals International |
| 2008-02-07 | 2007-11-30 | N-CSRS | Genentech Inc | DNA | US | Medical-Biomedical/Gene | 600 | Sold Some | -3,100 | -83.78 % | $41,952 | - | - | - % | | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Genentech Inc |
| 2008-02-07 | 2007-11-30 | N-CSRS | Celgene Corp | CELG | US | Medical-Biomedical/Gene | 800 | Added More | 200 | 33.33 % | $46,360 | $44,520 | $-1,840 | -3.96 % | $-460 | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Celgene Corp |
| 2008-02-07 | 2007-11-30 | N-CSRS | Genzyme Corp | GENZ | US | Medical-Biomedical/Gene | 446 | Sold Some | -200 | -30.95 % | $33,914 | $22,407 | $-11,507 | -33.92 % | $5,160 | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Genzyme Corp |
| 2008-02-07 | 2007-11-30 | N-CSRS | Gilead Sciences Inc | GILD | US | Therapeutics | 1,300 | No Change | 0 | 0 % | $57,759 | $61,113 | $3,354 | 5.80 % | $0 | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Gilead Sciences Inc |
| 2008-02-07 | 2007-11-30 | N-CSRS | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 100 | No Change | 0 | 0 % | $3,936 | $2,381 | $-1,555 | -39.50 % | $0 | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Myriad Genetics Inc |
| 2008-02-07 | 2007-11-30 | N-CSRS | Eli Lilly And Co | LLY | US | Medical-Drugs | 400 | No Change | 0 | 0 % | $20,488 | $14,720 | $-5,768 | -28.15 % | $0 | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Eli Lilly And Co |
| 2008-02-07 | 2007-11-30 | N-CSRS | Johnson And Johnson | JNJ | US | Medical Products | 700 | Sold Some | -300 | -30.00 % | $43,967 | $43,883 | $-84 | -0.19 % | $36 | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Johnson And Johnson |
| 2008-02-07 | 2007-11-30 | N-CSRS | Varian Medical Systems Inc | VAR | US | Medical Products | 500 | No Change | 0 | 0 % | $25,685 | $23,380 | $-2,305 | -8.97 % | $0 | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Varian Medical Systems Inc |
| 2008-02-07 | 2007-11-30 | N-CSRS | Merck And Co Incnj | MRK | US | Medical-Drugs | 500 | Sold Some | -400 | -44.44 % | $22,850 | $18,210 | $-4,640 | -20.30 % | $3,712 | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Merck And Co Incnj |
| 2008-02-07 | 2007-11-30 | N-CSRS | Novartis Ag | NVS | CH | Medical-Drugs | 0 | Sold All | -1,000 | -100 % | - | - | - | 11.46 % | $-5,630 | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Novartis Ag |
| 2008-02-07 | 2007-11-30 | N-CSRS | Qlt Inc | QLTI | CA | Therapeutics | 300 | Added More | 200 | 200.00 % | $1,014 | $1,155 | $141 | 13.90 % | $94 | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Qlt Inc |
| 2008-02-07 | 2007-11-30 | N-CSRS | Cell Therapeutics Inc | CTIC | US | Medical-Biomedical/Gene | 25 | Sold Some | -75 | -75.00 % | $40 | - | - | - % | | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Cell Therapeutics Inc |
| 2008-02-07 | 2007-11-30 | N-CSRS | Vertex Pharmaceuticals Inc | VRTX | US | Medical-Biomedical/Gene | 200 | No Change | 0 | 0 % | $3,802 | $7,872 | $4,070 | 107.04 % | $0 | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2008-02-07 | 2007-11-30 | N-CSRS | Biogen Idec Inc | BIIB | US | Medical-Biomedical/Gene | 675 | Added More | 100 | 17.39 % | $41,567 | $31,583 | $-9,983 | -24.01 % | $-1,479 | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Biogen Idec Inc |
| 2008-02-07 | 2007-11-30 | N-CSRS | Abbott Laboratories | ABT | US | Medical-Drugs | 600 | No Change | 0 | 0 % | $34,860 | $31,878 | $-2,982 | -8.55 % | $0 | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Abbott Laboratories |
| 2008-02-07 | 2007-11-30 | N-CSRS | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 325 | No Change | 0 | 0 % | $15,187 | $18,281 | $3,094 | 20.37 % | $0 | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Amgen Inc |
| 2008-02-07 | 2007-11-30 | N-CSRS | Cytyc Corp | CYTC | US | Diagnostic Equipment | 0 | Sold All | -400 | -100 % | - | - | - | - % | | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Cytyc Corp |
| 2008-02-07 | 2007-11-30 | N-CSRS | Wyeth | WYE | US | Medical-Drugs | 500 | No Change | 0 | 0 % | $20,435 | - | - | - % | | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Wyeth |
| 2008-02-07 | 2007-11-30 | N-CSRS | Schering-Plough Corp | SGP | US | Medical-Drugs | 600 | No Change | 0 | 0 % | $11,952 | - | - | - % | | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Schering-Plough Corp |
| 2008-02-07 | 2007-11-30 | N-CSRS | Pfizer Inc | PFE | US | Medical-Drugs | 1,050 | Sold Some | -950 | -47.50 % | $23,804 | $19,457 | $-4,347 | -18.26 % | $3,933 | | | | | | News Article | History of Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund Ownership Of Pfizer Inc |
![]() |
| |
Note: All amounts are based on price of stock at date reported versus the current price! They do not represent actual profit/loss!
There has been no adjustmentsfor splits! |
| Note: All amounts in USD, converted using Intrabank Exchange Rate on Date Reported/Today |
|
Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and may be inaccurate!
|
| Note: For security reasons, only (A-Z,a-z,0-9,space,period,colon,comma,forward slash,at) can be inputed - all others are stripped automatically! |
|
Copyright © 2007 All rights reserved. Please see our Terms of Use.
|
|
![]() |
RSS feed for Amidex Funds Inc - Amidex Cancer Innovations And Healthcare Fund